Dr. Jonathan Ross Dattilo, MD

Dr. Dattilo practices at SurgCenter Pinellas in Largo, Florida.

Dr. Dattilo's NPI, 1790101608, was assigned on March 16, 2014. Dr. Dattilo graduated from Johns Hopkins University School of Medicine in 2014. Dr. Dattilo holds Florida license ME144420.

Dr. Dattilo's primary practice is SurgCenter Pinellas, at 12416 66th St N, Ste D, Largo, FL 33773. The practice phone is (727) 408-5310.

Dr. Dattilo's primary practice is SurgCenter Pinellas in Largo, Florida. Dr. Dattilo is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is Alexander Orthopaedic Associates. Dmand AI also links Dr. Dattilo to 4 more hospitals, 2 home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dattilo practices, 9 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Dattilo's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Dattilo is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Dattilo's licenses on file in 4 states: Florida, Maryland, Virginia and Pennsylvania.

Dmand AI lists arthritis, bursitis, hip replacement, joint pain, knee arthroscopy, knee injury, knee replacement and lower back pain among the conditions Dr. Dattilo treats.

CMS data shows 4,174 Medicare services from Dr. Dattilo across 16 procedure codes in 2024, for 385 Medicare patients. Medicare paid $161,397 for them.

CMS counts 385 Medicare patients who saw Dr. Dattilo in 2024. The largest group is 65 to 74, with 214 patients. 75% of them have arthritis, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dattilo's median patient age at 70, with 61% women.

In 2024, Dr. Dattilo wrote 1,291 Medicare Part D claims for 312 patients. 100% of them were for generic drugs. CMS names the drug for 1,251 of them, across 11 drugs with 11 or more claims each, at $9,342 in total drug cost. In 2023, CMS named 789 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Dattilo for performance year 2024, reported as part of a group. Dr. Dattilo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 42 procedures of hip replacement by Dr. Dattilo, more than 84% of the clinicians it reports for that procedure.

Dmand AI links 30 papers to Dr. Dattilo, published from 2013 to 2023. 2016 was the busiest year, with 5. The most frequent topics are Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee and Comorbidity. Dr. Dattilo has published most often in J Arthroplasty. Dr. Dattilo's most frequent co-authors are Daniel J. Gittings, Chia Heng Wu, MD and Jiabin Liu, MD, PhD.

CMS Open Payments shows 93 general payments to Dr. Dattilo from 21 drug and device companies from 2016 to 2025. Education make up the largest share, 46% of the total. Smith & Nephew, Inc. paid the most, $9,771.

Dr. Dattilo graduated from Johns Hopkins University School of Medicine in 2014.

Dr. Dattilo is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.